proteasome inhibitor的意思|示意
蛋白酶体抑制剂
proteasome inhibitor的网络常见释义
蛋白酶体抑制剂 ...取最新 硼替佐米诱导骨髓瘤细胞未折迭蛋白反应及凋亡 董红娟 【摘要】： 背景和目的:蛋白酶体抑制剂(proteasome inhibitor, PI)作为一类新型抗肿瘤药物,自2003年被美国FDA批准用于治疗复发难治性多发性骨髓瘤(multiple...
蛋白解体抑制剂 Bortezomib是第一个新开发机转的药物—蛋白解体抑制剂(proteasome inhibitor),对于许多肿瘤类型均具有细胞毒性.
探讨蛋白酶体抑制剂 ...抑制剂诱导的PC12细胞帕金森病模型中血红素加氧酶-1的差异表达 加入收藏夹 目的 探讨蛋白酶体抑制剂(Proteasome inhibitor,PSI)诱导的PC12细胞帕金森病(Parkinson disease,PD)模型中血红素加氧酶-1(Hem...
proteasome inhibitor相关短语
1、 Proteasome inhibitor PS-341 蛋白酶体抑制剂PS
2、 proteasome inhibitor ps- 蛋白酶体抑制剂ps
3、 proteasome inhibitor MG132 蛋白酶体抑制剂MG
proteasome inhibitor相关例句
The proteasome inhibitor MG-132 can reduce the lung injury induced by hyperoxia and inhibit P38MAPK signaling pathway.
蛋白酶体抑制剂MG - 132可以减轻高氧引起的肺损伤，可能对p 38 MAPK信号通路有抑制作用。
Objective to explore the effects of proteasome inhibitor MG-132 on proliferation, apoptosis of U87 glioma cells in vitro.
目的探讨蛋白酶体抑制剂MG - 132对体外人u87胶质瘤细胞增殖和凋亡的影响。
Here, the relationship between UPS and myocardial reperfusion injury and the influence of proteasome inhibitor to myocardial reperfusion injury are reviewed.
现就泛素-蛋白酶体系统与心肌再灌注损伤的关系以及抑制蛋白酶体的活性后对心肌再灌注损伤的影响进行综述。
Objective To study the formation and development of inclusions in dopaminergic PC12 cells treated with proteasome inhibitor PSI.
目的研究蛋白酶体抑制剂PSI诱导PC12细胞胞浆内嗜酸性包涵体的形成及演变过程。
Bortezonib (velcade) is the first proteasome inhibitor that has entered clinical trial.
波替单抗(万珂)是第一个进入临床试验的蛋白酶体抑制剂。
PS 341 is a potent and selective inhibitor of the proteasome.
PS 341是蛋白酶体有效的选择性抑制药。